2 completed, 1 terminated. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Prolastin: new trials by email Literature Review of Prolastin trials Research Report on Prolastin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of (α1Proteinase Inhibitor, α1PI) in HIV Disease α1 Proteinase Inhibitor, Placebos - HIV Disease | Phase 2 / Phase 3 | Terminated | Institute for Human Genetics and Biochemistry | 12 | 2012-04-01 | 2020-08-31 |
| Therapy to Elevate CD4 Counts in HIV-1 Disease alpha-1-Proteinase Inhibitor - HIV Disease | Phase 2 / Phase 3 | Completed | Institute for Human Genetics and Biochemistry | 4 | 2006-12-01 | 2021-09-28 |
| The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency alpha-1 proteinase inhibitor (human) - Alpha 1-Antitrypsin Deficiency | Phase 3 | Completed | Grifols Therapeutics LLC | 38 | 2006-06-01 | 2014-08-19 |
Acquired Immunodeficiency Syndrome (2) · Pulmonary Emphysema (1) · alpha 1-Antitrypsin Deficiency (1)
Institute for Human Genetics and Biochemistry (2) · Grifols Therapeutics LLC (1)
United States (3) · United Kingdom (1)
Cynthia Bristow, PhD (1) · Cynthia L Bristow, PhD (1) · Jose Cortes, MD (1) · Kim Hanna, MSc (1)